Cargando…

Plasminogen activator inhibitor-1 activity and long-term outcome in patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention: a prospective cohort study

AIM: To determine the relationship between plasminogen activator inhibitor-1 (PAI-1) activity rise during the first 24 hours of ST-elevation myocardial infarction (STEMI) treatment and death after 5 years. METHODS: From May 1, 2009 to March 23, 2010, 87 STEMI patients treated with primary percutaneo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pavlov, Marin, Nikolić-Heitzler, Vjeran, Babić, Zdravko, Milošević, Milan, Kordić, Krešimir, Ćelap, Ivana, Degoricija, Vesna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Croatian Medical Schools 2018
Materias:	Clinical Science
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6045897/ https://www.ncbi.nlm.nih.gov/pubmed/29972733 http://dx.doi.org/10.3325/cmj.2018.59.108

Ejemplares similares

The influence of therapeutic hypothermia on the outcomes of cardiac arrest survivors: a retrospective cohort study
por: Pavlov, Marin, et al.
Publicado: (2020)

Importance of acute cardiac care registries at the national level
por: Đuzel, Ana, et al.
Publicado: (2020)

Unusual pattern of inferior vena cava thrombosis after veno-arterial extracorporeal membrane oxygenation: a report of two cases
por: Pavlov, Marin, et al.
Publicado: (2020)

Predictive role of plasminogen-activator-inhibitor-1 (PAI-1) in non-ST-segment elevation acute coronary syndrome
por: Sinkovic, A, et al.
Publicado: (2002)

CHANGES IN PHYSICAL ACTIVITY LEVELS IN PATIENTS WITH ACUTE CORONARY SYNDROME BETWEEN THE FIRST AND THIRD DECADES OF THE 21(st) CENTURY
por: Babić, Zdravko, et al.
Publicado: (2022)

Trend of Galectin-3 Levels in Patients with Non-ST-Elevation and ST-Elevation Myocardial Infarction
por: Mitić, Branka, et al.
Publicado: (2022)

Sustained postoperative plasma elevations of plasminogen activator inhibitor-1 following minimally invasive colorectal cancer resection
por: Kumara, H.M.C. Shantha, et al.
Publicado: (2022)

Localization of Urokinase‐type Plasminogen Activator, Plasminogen Activator Inhibitor‐1, 2 and Plasminogen in Colon Cancer
por: Naitoh, Hiroyuki, et al.
Publicado: (1995)

THE ACTIVATION OF PLASMINOGEN BY CHLOROFORM
por: Christensen, L. R.
Publicado: (1946)

Croatian Society of Medical Biochemistry and Laboratory Medicine: national recommendations for venous blood sampling
por: Nikolac, Nora, et al.
Publicado: (2013)

Plasminogen Activator Inhibitor-1 Protects Mice Against Cardiac Fibrosis by Inhibiting Urokinase-type Plasminogen Activator-mediated Plasminogen Activation
por: Gupta, Kamlesh K., et al.
Publicado: (2017)

Elevation of serum urokinase plasminogen activator receptor and liver stiffness in postoperative biliary atresia
por: Udomsinprasert, Wanvisa, et al.
Publicado: (2016)

Long-term direct oral anticoagulation in primary osteonecrosis with elevated plasminogen activation inhibitor
por: Haydock, Maria Monica, et al.
Publicado: (2019)

Plasminogen activator inhibitor-1 is elevated in patients with COPD independent of metabolic and cardiovascular function
por: Waschki, Benjamin, et al.
Publicado: (2017)

Enoxaparin Effect on Pregnancy Outcomes in a Patient with Elevated Plasminogen Activator Inhibitor-1
por: Minor, Kathleen, et al.
Publicado: (2020)

Plasminogen activator inhibitor is significantly elevated in liver transplant recipients with decompensated NASH cirrhosis
por: Rivas, Gloriany, et al.
Publicado: (2021)

Prehospital Activation of the Cardiac Catheterization Laboratory in ST‐Segment–Elevation Myocardial Infarction for Primary Percutaneous Coronary Intervention
por: Savage, Michael L., et al.
Publicado: (2023)

Yersinia pestis Plasminogen Activator
por: Sebbane, Florent, et al.
Publicado: (2020)

The Elevated Soluble ST2 Predicts No-Reflow Phenomenon in ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
por: Somuncu, Mustafa Umut, et al.
Publicado: (2019)

Plasminogen and Plasminogen Activators Protect against Renal Injury in Crescentic Glomerulonephritis
por: Kitching, A. Richard, et al.
Publicado: (1997)

Tissue Plasminogen Activator and Plasminogen Activator Inhibitor-1 Levels in Patients with Acute Paraquat Intoxication
por: Seok, Su-Jin, et al.
Publicado: (2011)

Structural basis of specific inhibition of tissue-type plasminogen activator by plasminogen activators inhibitor-1
por: Gong, Lihu, et al.
Publicado: (2016)

Role of tissue-type plasminogen activator and plasminogen activator inhibitor-1 in psychological stress and depression
por: Tsai, Shih-Jen
Publicado: (2017)

Plasma tissue plasminogen activator and plasminogen activator inhibitor-1 in hospitalized COVID-19 patients
por: Zuo, Yu, et al.
Publicado: (2021)

Soluble Urokinase Plasminogen Activator Receptor (suPAR) Concentrations Are Elevated in Patients with Neuroendocrine Malignancies
por: Özdirik, Burcin, et al.
Publicado: (2020)

Percutaneous coronary intervention in the elderly with ST-segment elevation myocardial infarction
por: Gao, Lei, et al.
Publicado: (2014)

Primary percutaneous coronary intervention for ST elevation myocardial infarction in nonagenarians
por: Petroni, Thibaut, et al.
Publicado: (2016)

Cyclic ST-segment elevation after primary percutaneous coronary intervention
por: Jansen, W. P. J.
Publicado: (2020)

Premature delivery impacts the concentration of plasminogen activators and a plasminogen activator inhibitor and the plasmin activity in human milk
por: Demers-Mathieu, Veronique, et al.
Publicado: (2022)

A Rare Case of Persistent ST-Elevation Myocardial Infarction Post-Tissue Plasminogen Activator With White Clot Extraction in a Middle-Aged Woman on Medroxyprogesterone Acetate
por: Fatmi, Syed S, et al.
Publicado: (2022)

Impact of intracoronary contrast injection pressure on reperfusion during primary percutaneous coronary intervention in acute ST-segment elevation myocardial infarction: A prospective randomized pilot study
por: Stambuk, Kresimir, et al.
Publicado: (2019)

Plasminogen activator activity in tears of pregnant women
por: Csutak, Adrienne, et al.
Publicado: (2017)

Prognostic significance of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in primary breast cancer.
por: Knoop, A., et al.
Publicado: (1998)

Relationship between tissue plasminogen activator, plasminogen activator inhibitor and CT image in chronic subdural hematoma.
por: Lim, D. J., et al.
Publicado: (1995)

Zinc-Triggered Induction of Tissue Plasminogen Activator and Plasminogen in Endothelial Cells and Pericytes
por: Cho, Mun-Kyung, et al.
Publicado: (2013)

Ligand binding modulates the structural dynamics and activity of urokinase-type plasminogen activator: A possible mechanism of plasminogen activation
por: Kromann-Hansen, Tobias, et al.
Publicado: (2018)

Curcumin: Biological Activities and Modern Pharmaceutical Forms
por: Urošević, Maja, et al.
Publicado: (2022)

Elevated levels of serum urokinase plasminogen activator predict poor prognosis in hepatocellular carcinoma after resection
por: Tsai, Ming-Chao, et al.
Publicado: (2019)

Elevated plasma levels of plasminogen activator inhibitor‐1 are associated with risk of future incident venous thromboembolism
por: Frischmuth, Tobias, et al.
Publicado: (2022)

Elevated Tumor Cell-Intrinsic STING Expression in Advanced Laryngeal Cancer
por: Viculin, Jelena, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_uc2cad0vnb8i5cb076820o0grc